Chimerix Stock Current Valuation
| CMRX Stock | USD 8.50 0.03 0.35% |
Valuation analysis of Chimerix helps investors to measure Chimerix's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Enterprise Value is likely to rise to about 325.6 M in 2025, whereas Enterprise Value Over EBITDA is likely to drop (3.06) in 2025. Fundamental drivers impacting Chimerix's valuation include:
Fairly Valued
Today
Please note that Chimerix's price fluctuation is unstable at this time. Calculation of the real value of Chimerix is based on 3 months time horizon. Increasing Chimerix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Chimerix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chimerix Stock. However, Chimerix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.5 | Real 8.54 | Target 8.4 | Hype 8.52 |
The intrinsic value of Chimerix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chimerix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Chimerix helps investors to forecast how Chimerix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chimerix more accurately as focusing exclusively on Chimerix's fundamentals will not take into account other important factors: Chimerix Company Current Valuation Analysis
Chimerix's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Chimerix Current Valuation | 660.18 M |
Most of Chimerix's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chimerix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chimerix Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Chimerix is extremely important. It helps to project a fair market value of Chimerix Stock properly, considering its historical fundamentals such as Current Valuation. Since Chimerix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chimerix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chimerix's interrelated accounts and indicators.
Click cells to compare fundamentals
Chimerix Current Valuation Historical Pattern
Today, most investors in Chimerix Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chimerix's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chimerix current valuation as a starting point in their analysis.
Chimerix Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Chimerix has a Current Valuation of 660.18 M. This is 95.4% lower than that of the Biotechnology sector and 85.79% lower than that of the Health Care industry. The current valuation for all United States stocks is 96.03% higher than that of the company.
Chimerix Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chimerix's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chimerix could also be used in its relative valuation, which is a method of valuing Chimerix by comparing valuation metrics of similar companies.Chimerix is currently under evaluation in current valuation category among its peers.
Chimerix Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chimerix from analyzing Chimerix's financial statements. These drivers represent accounts that assess Chimerix's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chimerix's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 300.3M | 546.1M | 162.9M | 85.3M | 312.2M | 374.7M | |
| Enterprise Value | 256.2M | 547.1M | 139.1M | 58.9M | 281.1M | 325.6M |
Chimerix ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Chimerix's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Chimerix's managers, analysts, and investors.Environmental | Governance | Social |
Chimerix Fundamentals
| Return On Equity | -0.49 | ||||
| Return On Asset | -0.3 | ||||
| Operating Margin | (953.58) % | ||||
| Current Valuation | 660.18 M | ||||
| Shares Outstanding | 93.05 M | ||||
| Shares Owned By Insiders | 6.74 % | ||||
| Shares Owned By Institutions | 52.90 % | ||||
| Number Of Shares Shorted | 4.14 M | ||||
| Price To Earning | (3.43) X | ||||
| Price To Book | 6.50 X | ||||
| Price To Sales | 4,974 X | ||||
| Revenue | 212 K | ||||
| Gross Profit | (73.39 M) | ||||
| EBITDA | (96.57 M) | ||||
| Net Income | (88.39 M) | ||||
| Cash And Equivalents | 42.79 M | ||||
| Cash Per Share | 0.49 X | ||||
| Total Debt | 24.33 M | ||||
| Debt To Equity | 0.1 % | ||||
| Current Ratio | 2.18 X | ||||
| Book Value Per Share | 1.51 X | ||||
| Cash Flow From Operations | (74.98 M) | ||||
| Short Ratio | 2.65 X | ||||
| Earnings Per Share | (0.99) X | ||||
| Target Price | 8.54 | ||||
| Number Of Employees | 72 | ||||
| Beta | 0.32 | ||||
| Market Capitalization | 790.9 M | ||||
| Total Asset | 146.01 M | ||||
| Retained Earnings | (883.91 M) | ||||
| Working Capital | 170.67 M | ||||
| Current Asset | 228.84 M | ||||
| Current Liabilities | 20.18 M | ||||
| Net Asset | 146.01 M |
About Chimerix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chimerix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chimerix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chimerix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chimerix Stock Analysis
When running Chimerix's price analysis, check to measure Chimerix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chimerix is operating at the current time. Most of Chimerix's value examination focuses on studying past and present price action to predict the probability of Chimerix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chimerix's price. Additionally, you may evaluate how the addition of Chimerix to your portfolios can decrease your overall portfolio volatility.